Alx Oncology Holdings
ALXO
$1.06+6.00%
End of day · as of Oct 17, 2026, 2:00 AM ET
Mkt cap
$207.23M
EV/Sales
N/A
P/E ratio
N/A
FY2022 Revenue
N/A
EPS (H1 2026)
$-0.30
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
N/A
Beta
0.41
Div yield
N/A
Sector
Healthcare
Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.
Latest reported ALXO revenue for 2022-12-31 was $0. Net income was -$123.5M. ALXO currently screens at market cap $207.2M.
Use this ALXO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ALXO income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Alx Oncology Holdings (ALXO) is a biotechnology company in the Healthcare sector.
Latest cached Alx Oncology Holdings (ALXO) net income for Dec 31, 2022 was -$123.5M. Statements: https://lician.com/financials/alxo
Alx Oncology Holdings (ALXO) market capitalization is $207.2M on the latest cached snapshot.
Alx Oncology Holdings (ALXO) cached previous close $1.00; day range $1.00 – $1.07; volume 2,202,205. Session quote: https://lician.com/quote/alxo
Alx Oncology Holdings (ALXO) latest cached earnings event is "ALXO earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ALXO filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/alxo